Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
34.72
+0.23 (0.67%)
Last updated: Jul 17, 2025
SHE:301089 Market Cap
SHE:301089 has a market cap or net worth of 4.39 billion as of July 18, 2025. Its market cap has increased by 5.79% in one year.
Market Cap
4.39B
Enterprise Value
4.12B
Revenue
410.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.72
Market Cap Chart
Since October 27, 2021, SHE:301089's market cap has increased from 3.63B to 4.39B, an increase of 21.03%. That is a compound annual growth rate of 5.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 18, 2025 | 4.39B | 23.20% |
Dec 31, 2024 | 3.57B | -47.81% |
Dec 29, 2023 | 6.83B | -24.66% |
Dec 30, 2022 | 9.07B | -10.45% |
Dec 31, 2021 | 10.13B | 178.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 391.84B |
Shenzhen Mindray Bio-Medical Electronics | 272.50B |
WuXi AppTec | 236.12B |
Sichuan Biokin Pharmaceutical | 128.74B |
Zhangzhou Pientzehuang Pharmaceutical., | 120.04B |
Aier Eye Hospital Group | 116.29B |
Shanghai United Imaging Healthcare | 104.88B |
Yunnan Baiyao Group Co.,Ltd | 100.33B |